Crispr Therapeutics shares owned by KBC Group NV
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by KBC Group NV
from 13F filings
Historical chart of KBC Group NV investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by KBC Group NV
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $5.6M | 117k | 47.57 |
| 2025-12-31 | $149k | 2.9k | 52.28 |
| 2025-06-30 | $108k | 2.2k | 48.56 |
| 2025-03-31 | $128k | 3.8k | 34.13 |
| 2024-12-31 | $2.4M | 61k | 39.36 |
| 2024-09-30 | $132k | 2.8k | 46.84 |
| 2024-06-30 | $106k | 2.0k | 54.14 |
| 2024-03-31 | $110k | 1.6k | 68.45 |
| 2023-09-30 | $73k | 1.6k | 45.43 |
| 2021-09-30 | $67k | 600 | 111.67 |
| 2021-06-30 | $97k | 600 | 161.67 |
| 2021-03-31 | $73k | 600 | 121.67 |
| 2020-12-31 | $92k | 600 | 153.33 |
| 2020-09-30 | $100k | 1.2k | 83.33 |
| 2020-06-30 | $88k | 1.2k | 73.33 |
| 2020-03-31 | $51k | 1.2k | 42.50 |
| 2019-12-31 | $73k | 1.2k | 60.83 |
| 2019-09-30 | $7.0k | 165 | 42.42 |
| 2019-06-30 | $57k | 1.2k | 47.50 |
| 2019-03-31 | $43k | 1.2k | 35.83 |
| 2018-12-31 | $34k | 1.2k | 28.33 |
| 2018-09-30 | $53k | 1.2k | 44.17 |
| 2018-06-30 | $71k | 1.2k | 59.17 |
| 2018-03-31 | $78k | 1.7k | 45.88 |
| 2017-12-31 | $16k | 700 | 22.86 |